Application no. and date | 22704693.5 (espacenet) (Federated) (European Patent Register), 20220129 | Patent/reg. no. and date | DK/EP 4225291, 20240313 | Publication date | 20230816 | Priority no. and date | US 202163144355 P, 20210201 | EP pub. no. and date |
EP 4225291 20230816 | Effective date | | Applicant/owner | CymaBay Therapeutics, Inc., 7575 Gateway Boulevard, Suite 110
Newark, CA 94560, US | Applicant ref. no. | V476295DK00 | Inventor | CHOI, Yun-Jung,
Newark, CA 94560, US, MCWHERTER, Charles A.,
Newark, CA 94560, US, STEINBERG, Alexandra S.,
Newark, CA 94560, US, YANG, Ke,
Newark, CA 94560, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/192 (2006.01) , A61K 45/06 (2006.01) , A61P 1/16 (2006.01) | Title | Behandling af cholangiopati med seladelpar | Int. application no. | US2022014464 | Int. publication no. | WO2022165288 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|